Revance's RHA Dynamic Volume received FDA clearance for midface augmentation and age-related volume loss, expanding the RHA product line beyond its original dynamic-expression focus. RHA fillers are engineered to move with facial expression (lower G-prime, higher elasticity) and are positioned as a bridge between traditional HA fillers and biostimulators in the volumization hierarchy.
The midface indication is clinically significant: it's a high-visibility zone where volume loss drives patient demand, and the dynamic properties of RHA may offer advantages over static HA fillers in maintaining natural movement. This directly competes with Juvéderm Voluma, Restylane Lyft, and off-label use of biostimulators like Radiesse and Sculptra.